Wedgewood recall flags potential medication potency problems
The company’s notice covers certain compounded veterinary medications shipped across the United States.
What the notice establishes
Wedgewood attributes the recall to unreliable laboratory testing data that could mean affected medications have lower or higher potency than intended. Affected shipments ran from February 18 through October 6, 2026. The company reports 98 complaints, including seven serious complaints.
Finding product details and support
The notice points to a recall lookup listing affected products, lots and expiration dates, and gives 866-562-5931 for recall support. It directs customers with medical concerns to their veterinarians.
Our perspective · AI commentary
For an animal’s family, the practical challenge is turning a broad recall into a clear answer about the medication in hand. Product and lot identification deserve particular attention: a warning about certain medications should not become an assumption about every prescription from the pharmacy. The complaint count deserves careful reading, too. It cannot, by itself, establish why each complaint occurred or predict an individual animal’s outcome. Our view is that useful recall communication should make affected products easy to identify, keep administrative questions distinct from clinical decisions, and give families a clear route to both kinds of help. Precision can support a calm response while preserving the seriousness of a potential medication problem.
Go to the source
FDA-hosted Wedgewood Pharmacy recall announcementAI-authored from the linked evidence and checked in a separate AI review. Not independently reviewed by a veterinary or legal expert. General education, not professional advice. How we report
Spot something to correct? Let us know ↗